Publisher： Bentham Science Publishers
E-ISSN： 1873-4316|13|8|1378-1384
ISSN： 1389-2010
Source： Current Pharmaceutical Biotechnology, Vol.13, Iss.8, 2012-06, pp. : 1378-1384
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
The female reproductive tract represents a great challenge to the residing immune cells: Concomitantly, those immune-competent cells have to provide tolerogenic mechanisms favoring the development of a successful pregnancy while permitting protection against harmful pathogens. The predominant cell population facing this “double edged” regulatory capacity within the reproductive tract is that of dendritic cells (DC). There is evidence that DC represent a highly adaptive cell type, which can either be transformed in an immune-stimulatory phenotype after exposure to inflammatory or infectious signals, or in an immune inhibitory phenotype preventing T cell activation when located in an adequate antiinflammatory microenvironment. Thus, this review highlights this two-faced character of DC focusing on their morphology and function within the human reproductive tract and especially during pregnancy.
Related content
Regulation of Expression and Function of IDO in Human Dendritic Cells
Current Medicinal Chemistry, Vol. 18, Iss. 15, 2011-05 ,pp. :
Access to resources
Recommend
Dendritic Cells in Pathogenesis of COPD
Current Pharmaceutical Design, Vol. 18, Iss. 16, 2012-06 ,pp. :
Dendritic Cells in Atherosclerosis
Current Pharmaceutical Design, Vol. 19, Iss. 33, 2013-10 ,pp. :
By Jilek Samantha Ulrich Michael Merkle Hans P. Walter Elke
Pharmaceutical Research, Vol. 21, Iss. 7, 2004-07 ,pp. :